Originally approved for type 2 diabetes management, semaglutide has gained prominence for its efficacy in weight loss and potential benefits in cardiovascular and metabolic health
GLP-1 (glucagon-like peptide-1) agonists are FDA-approved medications that mimic a natural hormone, helping regulate blood sugar and reduce hunger
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about individual variation in peptide metabolism and GLP-1 pathway response
With growing accessibility, households with at least one GLP-1 user have experienced a 5.5% decrease in their grocery spending within six months of adoption
B12 Energy Plus May Boost Energy and Stamina May Release Antioxidants in the Body May Reduce Anxiety and Irritability May Provide Results in Minutes, May Last for Hours NO Sugar Crash, NO Sodium May Restore Mental Clarity, MayImprove Memory Safe, Easy and Convenient to Use ARE YOU GETTING ENOUGH SLEEP
As of January this year, California, New Hampshire, Pennsylvania and South Carolina ended Medicaid GLP-1 drug coverage for weight loss, and Michigan started restricting coverage to people classified as morbidly obese, meaning they have a body mass index above 40